During the past decade, Optimum Profesorskie Centrum Okulistyki conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Optimum Profesorskie Centrum Okulistyki" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Allergan" with 3 trials sponsored, "Kodiak Sciences Inc" with 2 trials sponsored, "Alkahest, Inc." with 1 trials sponsored and "Clearside Biomedical, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Optimum Profesorskie Centrum Okulistyki" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Optimum Profesorskie Centrum Okulistyki" are "Diabetic Macular Edema" (3 trials), "Geographic Atrophy" (3 trials), "Macular Edema" (3 trials), "Neovascular Age-related Macular Degeneration" (2 trials) and "Retinal Vein Occlusion" (2 trials). Many other conditions were trialed in "Optimum Profesorskie Centrum Okulistyki" in a lesser frequency.

Most popular intervention types in "Optimum Profesorskie Centrum Okulistyki" are "Drug" (14 trials), "Other" (8 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (8 trials), "Aflibercept" (6 trials), "Faricimab" (5 trials), "KSI-301" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Optimum Profesorskie Centrum Okulistyki" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Optimum Profesorskie Centrum Okulistyki". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Optimum Profesorskie Centrum Okulistyki, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Optimum Profesorskie Centrum Okulistyki, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".